SNAP25 is associated with schizophrenia and major depressive disorder in the Han Chinese population

Journal of Clinical Psychiatry

Volumn 76, Issue 1, 2015, Pages e76-e82

  Wang, Qingzhong ^a,b   Wang, Yanlin ^b   Ji, Weidong ^b,d   Zhou, Guoquan ^b,e   He, Kuanjun ^b   Li, Zhiqiang ^b   Chen, Jianhua ^b,f   Li, Wenjin ^b   Wen, Zujia ^b   Shen, Jiawei ^b   Qiang, Yu ^b   Ji, Jue ^b   Wang, Yujiong ^g   Shi, Yongyong ^a,b,d   Yi, Qizhong ^a   Wang, Yonggang ^b,c  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Shanghai Drug Abuse Treatment Centre   (China)

^e Institute of Neuropsychiatric Science and Systems Biological Medicine Shanghai Jiao Tong University ^*  (China)

^f SHANGHAI MENTAL HEALTH CENTER   (China)

^g NINGXIA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SNARE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; FEMALE; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; META ANALYSIS (TOPIC); NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; CHINA; ETHNOLOGY; GENETICS; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; CHINA; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 84925369140     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08962     Document Type: Article

References (40)

1. Ghaemi SN. Paradigms of psychiatry: eclecticism and its discontents. Curr Opin Psychiatry. 2006;19(6):619-624.
2. Craddock N, O'Donovan MC, Owen MJ. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet. 2005;42(3):193-204.
3. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187-1192.
4. Spitzer RL. DSM-IV-TR Case Book. Arlington, VA: American Psychiatric Publishing; 2002.
5. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552-1562.
6. Gershon ES, Alliey-Rodriguez N, Liu C. After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am J Psychiatry. 2011;168(3):253-256.
7. Frazer KA, Murray SS, Schork NJ, et al. Human genetic variation and its contribution to complex traits. Nat Rev Genet. 2009;10(4):241-251.
8. Lee SH, Ripke S, Neale BM, et al International Inflammatory Bowel Disease Genetics Consortium (IIBDGC). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-994.
9. Smoller JW, Craddock N, Kendler K, et al Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381(9875):1371-1379.
10. Wang Y, Tang BL. SNAREs in neurons - beyond synaptic vesicle exocytosis [review]. Mol Membr Biol. 2006;23(5):377-384.
11. Thompson PM, Sower AC, Perrone-Bizzozero NI. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry. 1998;43(4):239-243.
12. Thompson PM, Egbufoama S, Vawter MP. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(3):411-417.
13. Young CE, Arima K, Xie J, et al. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex. 1998;8(3):261-268.
14. Karson CN, Mrak RE, Schluterman KO, et al. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality.' Mol Psychiatry. 1999;4(1):39-45.
15. Fatemi SH, Earle JA, Stary JM, et al. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport. 2001;12(15):3257-3262.
16. Carroll LS, Kendall K, O'Donovan MC, et al. Evidence that putative ADHD low risk alleles at SNAP25 may increase the risk of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7):893-899.
17. Fanous AH, Zhao Z, van den Oord EJ, et al. Association study of SNAP25 and schizophrenia in Irish family and case-control samples. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):663-674.
18. Kawashima K, Kishi T, Ikeda M, et al. No association between tagging SNPs of SNARE complex genes (STX1A, VAMP2 and SNAP25) and schizophrenia in a Japanese population. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(7):1327-1331.
19. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265.
20. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97-98.
21. Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009;19(4):519-523.
22. Corradini I, Verderio C, Sala M, et al. SNAP-25 in neuropsychiatric disorders. Ann N Y Acad Sci. 2009;1152(1):93-99.
23. Hess EJ, Jinnah HA, Kozak CA, et al. Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J Neurosci. 1992;12(7):2865-2874.
24. Steffensen SC, Henriksen SJ, Wilson MC. Transgenic rescue of SNAP-25 restores dopamine-modulated synaptic transmission in the coloboma mutant. Brain Res. 1999;847(2):186-195.
25. Brophy K, Hawi Z, Kirley A, et al. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry. 2002;7(8):913-917.
26. Mill J, Curran S, Kent L, et al. Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Genet. 2002;114(3):269-271.
27. Feng Y, Crosbie J, Wigg K, et al. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry. 2005;10(11):998-1005, 973.
28. Brookes K, Xu X, Chen W, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006;11(10):934-953.
29. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet. 2009;126(1):13-50.
30. Green EK, Grozeva D, Jones I, et al Wellcome Trust Case Control Consortium. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry. 2010;15(10):1016-1022.
31. Kim JW, Biederman J, Arbeitman L, et al. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(6):781-790.
32. Etain B, Dumaine A, Mathieu F, et al. A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain. Mol Psychiatry. 2010;15(7):748-755.
33. Mishra PJ, Mishra PJ, Banerjee D, et al. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle. 2008;7(7):853-858.
34. Saunders MA, Liang H, Li W-H. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007;104(9):3300-3305.
35. Gong J, Tong Y, Zhang HM, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012;33(1):254-263.
36. Clayton D, Jones H. Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet. 1999;65(4):1161-1169.
37. Akey J, Jin L, Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet. 2001;9(4):291-300.
38. Musil R, Spellmann I, Riedel M, et al. SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. J Psychiatr Res. 2008;42(12):963-970. doi:10.1016/j.jpsychires.2007.11.003 PubMed
39. Golimbet VE, Alfimova MV, Gritsenko IK, et al. Association between a synaptosomal protein (SNAP-25) gene polymorphism and verbal memory and attention in patients with endogenous psychoses and mentally healthy subjects. Neurosci Behav Physiol. 2010;40(4):461-465.
40. Lochman J, Balcar VJ, Stastný F, et al. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes. Psychiatry Res. 2013;205(1-2):7-12.